封面
市場調查報告書
商品編碼
1435121

自動注射器市場:按適應症、應用、最終用戶分類 - 全球預測 2024-2030

Auto-disable Syringes Market by Indication (Infectious Diseases, Inflammatory/Auto-Immune Diseases), Application (Blood Collection, Drug Delivery, Vaccination), End-User - Global Forecast 2024-2030

出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年自動注射器市場規模為232.8億美元,預計2024年將達259.4億美元,2030年將達到500.1億美元,複合年成長率為11.54%。

自動注射器的全球市場

主要市場統計
基準年[2023] 232.8億美元
預測年份 [2024] 259.4億美元
預測年份 [2030] 500.1億美元
複合年成長率(%) 11.54%
自動注射器市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估自動注射器市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。

市場佔有率分析

市場佔有率分析是一種綜合工具,可以對自動注射器市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解:

1-市場滲透率:提供有關主要企業所服務的市場的全面資訊。

2-市場開拓:我們深入研究利潤豐厚的新興市場並分析其在成熟細分市場的滲透率。

3- 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題:

1-自動注射器市場的市場規模與預測是多少?

2-自動注射器市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?

3-自動注射器市場的技術趨勢和法律規範是什麼?

4-自動注射器市場主要供應商的市場佔有率是多少?

5-進入自動注射器市場適合的型態和策略手段是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 針刺傷和交叉感染的發生率增加
      • 醫療機構強烈傾向使用自動注射器
      • 疫苗接種覆蓋率需求增加
    • 抑制因素
      • 採購成本和原物料成本高
    • 機會
      • 擴大群眾應用宣傳活動範圍
      • 自動注射器的不斷進步
    • 任務
      • 對不安全注射操作和後勤挑戰的擔憂
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 自動注射器市場的適應症

  • 感染疾病
  • 發炎疾病/自體免疫疾病

第7章自動注射器市場:依應用分類

  • 血液收集
  • 藥物輸送
  • 疫苗接種

第8章自動注射器市場:依最終使用者分類

  • 門診手術中心
  • 診斷實驗室
  • 醫院

第9章美洲自動注射器市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太自動注射器市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲自動注射器市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析:主要企業
  • 主要企業競爭情境分析

第13章競爭產品組合

  • 主要公司簡介
    • AccuPoint by AdvaCare Pharma
    • Al Shifa Medical Products Co.
    • Apple Syringe
    • Becton Dickinson & Company
    • Duopross Meditech Corp.
    • Hindustan Syringes & Medical Devices Ltd
    • Hunan Pingan Medical Device Technology Co., Ltd. by Winner Medical Co.
    • Injecto A/S
    • Iscon Surgicals Ltd.
    • JMI SYRINGES & MEDICAL DEVICES LTD.
    • Merck KGaA
    • PT Oneject Indonesia
    • Retractable Technologies, Inc.
    • Sanavita Pharmaceuticals GmbH
    • Shandong Zhushi Pharmaceutical Group Co.,Ltd.
    • Shanghai Kohope Medical Devices Co., Ltd.
    • Shenzhen Medis Medical
    • Terumo Corporation
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-D86B4AA1ED24

[199 Pages Report] The Auto-disable Syringes Market size was estimated at USD 23.28 billion in 2023 and expected to reach USD 25.94 billion in 2024, at a CAGR 11.54% to reach USD 50.01 billion by 2030.

Global Auto-disable Syringes Market

KEY MARKET STATISTICS
Base Year [2023] USD 23.28 billion
Estimated Year [2024] USD 25.94 billion
Forecast Year [2030] USD 50.01 billion
CAGR (%) 11.54%
Auto-disable Syringes Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Auto-disable Syringes Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Auto-disable Syringes Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Auto-disable Syringes Market, highlighting leading vendors and their innovative profiles. These include AccuPoint by AdvaCare Pharma, Al Shifa Medical Products Co., Apple Syringe, Becton Dickinson & Company, Duopross Meditech Corp., Hindustan Syringes & Medical Devices Ltd, Hunan Pingan Medical Device Technology Co., Ltd. by Winner Medical Co., Injecto A/S, Iscon Surgicals Ltd., JMI SYRINGES & MEDICAL DEVICES LTD., Merck KGaA, PT Oneject Indonesia, Retractable Technologies, Inc., Sanavita Pharmaceuticals GmbH, Shandong Zhushi Pharmaceutical Group Co.,Ltd., Shanghai Kohope Medical Devices Co., Ltd., Shenzhen Medis Medical, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Auto-disable Syringes Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Infectious Diseases
    • Inflammatory/Auto-Immune Diseases
  • Application
    • Blood Collection
    • Drug Delivery
    • Vaccination
  • End-User
    • Ambulatory Surgical Centers
    • Diagnostic Laboratories
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Auto-disable Syringes Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Auto-disable Syringes Market?

3. What are the technology trends and regulatory frameworks in the Auto-disable Syringes Market?

4. What is the market share of the leading vendors in the Auto-disable Syringes Market?

5. Which modes and strategic moves are suitable for entering the Auto-disable Syringes Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Auto-disable Syringes Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of needle stick injuries and cross infection
      • 5.1.1.2. Significant preference of healthcare organizations towards the use of auto-disable syringes
      • 5.1.1.3. Increasing demand for immunization coverage
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of procurement and raw material
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing scope in mass application campaign
      • 5.1.3.2. Ongoing advancements in auto-disable syringes
    • 5.1.4. Challenges
      • 5.1.4.1. Concern regarding unsafe injection practices and logistic challenges
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Auto-disable Syringes Market, by Indication

  • 6.1. Introduction
  • 6.2. Infectious Diseases
  • 6.3. Inflammatory/Auto-Immune Diseases

7. Auto-disable Syringes Market, by Application

  • 7.1. Introduction
  • 7.2. Blood Collection
  • 7.3. Drug Delivery
  • 7.4. Vaccination

8. Auto-disable Syringes Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Diagnostic Laboratories
  • 8.4. Hospitals

9. Americas Auto-disable Syringes Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Auto-disable Syringes Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Auto-disable Syringes Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. AccuPoint by AdvaCare Pharma
    • 13.1.2. Al Shifa Medical Products Co.
    • 13.1.3. Apple Syringe
    • 13.1.4. Becton Dickinson & Company
    • 13.1.5. Duopross Meditech Corp.
    • 13.1.6. Hindustan Syringes & Medical Devices Ltd
    • 13.1.7. Hunan Pingan Medical Device Technology Co., Ltd. by Winner Medical Co.
    • 13.1.8. Injecto A/S
    • 13.1.9. Iscon Surgicals Ltd.
    • 13.1.10. JMI SYRINGES & MEDICAL DEVICES LTD.
    • 13.1.11. Merck KGaA
    • 13.1.12. PT Oneject Indonesia
    • 13.1.13. Retractable Technologies, Inc.
    • 13.1.14. Sanavita Pharmaceuticals GmbH
    • 13.1.15. Shandong Zhushi Pharmaceutical Group Co.,Ltd.
    • 13.1.16. Shanghai Kohope Medical Devices Co., Ltd.
    • 13.1.17. Shenzhen Medis Medical
    • 13.1.18. Terumo Corporation
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. AUTO-DISABLE SYRINGES MARKET RESEARCH PROCESS
  • FIGURE 2. AUTO-DISABLE SYRINGES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. AUTO-DISABLE SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. AUTO-DISABLE SYRINGES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. AUTO-DISABLE SYRINGES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. AUTO-DISABLE SYRINGES MARKET DYNAMICS
  • FIGURE 7. AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 8. AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. AUTO-DISABLE SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. AUTO-DISABLE SYRINGES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. AUTO-DISABLE SYRINGES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. AUTO-DISABLE SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 6. AUTO-DISABLE SYRINGES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. AUTO-DISABLE SYRINGES MARKET SIZE, BY INFLAMMATORY/AUTO-IMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. AUTO-DISABLE SYRINGES MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. AUTO-DISABLE SYRINGES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AUTO-DISABLE SYRINGES MARKET SIZE, BY VACCINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. AUTO-DISABLE SYRINGES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AUTO-DISABLE SYRINGES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AUTO-DISABLE SYRINGES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. AUTO-DISABLE SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 144. AUTO-DISABLE SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. AUTO-DISABLE SYRINGES MARKET LICENSE & PRICING